Publications in collaboration with researchers from University of Paris-Saclay (1)

2024

  1. Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia

    New England Journal of Medicine, Vol. 391, Núm. 6, pp. 493-503